Stericycle, Inc. (NASDAQ:SRCL) – William Blair decreased their FY2017 earnings per share estimates for shares of Stericycle in a research note issued to investors on Wednesday. William Blair analyst R. Daniels now expects that the business services provider will earn $4.46 per share for the year, down from their prior estimate of $4.60. William Blair has a “Ourperform” rating on the stock. William Blair also issued estimates for Stericycle’s Q4 2017 earnings at $1.12 EPS, Q1 2018 earnings at $1.13 EPS, Q2 2018 earnings at $1.18 EPS, Q3 2018 earnings at $1.11 EPS and FY2018 earnings at $4.46 EPS.
Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.04). Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The firm had revenue of $883.00 million during the quarter, compared to the consensus estimate of $896.81 million. During the same quarter in the prior year, the firm posted $1.24 earnings per share. The company’s revenue was down .8% on a year-over-year basis.
COPYRIGHT VIOLATION NOTICE: “Research Analysts Set Expectations for Stericycle, Inc.’s FY2017 Earnings (SRCL)” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2017/11/12/research-analysts-set-expectations-for-stericycle-inc-s-fy2017-earnings-srcl.html.
Other equities research analysts have also recently issued reports about the company. Stifel Nicolaus restated a “buy” rating and issued a $85.00 price objective (down from $95.00) on shares of Stericycle in a research note on Thursday. Jefferies Group LLC set a $108.00 price objective on Stericycle and gave the company a “buy” rating in a research note on Tuesday, October 17th. Zacks Investment Research cut Stericycle from a “buy” rating to a “hold” rating in a research note on Monday, August 7th. BMO Capital Markets lowered their price objective on Stericycle from $74.00 to $62.00 and set a “market perform” rating on the stock in a research note on Friday. Finally, Barrington Research lowered their price objective on Stericycle from $87.00 to $75.00 and set an “outperform” rating on the stock in a research note on Friday. Four research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $77.17.
Shares of Stericycle (NASDAQ:SRCL) opened at $64.02 on Friday. Stericycle has a 52 week low of $61.62 and a 52 week high of $88.00. The stock has a market capitalization of $5,468.99, a PE ratio of 14.76, a P/E/G ratio of 1.75 and a beta of 0.19. The company has a quick ratio of 0.87, a current ratio of 0.82 and a debt-to-equity ratio of 0.93.
Several hedge funds have recently bought and sold shares of SRCL. Pacer Advisors Inc. increased its position in shares of Stericycle by 8.4% in the second quarter. Pacer Advisors Inc. now owns 1,880 shares of the business services provider’s stock worth $143,000 after purchasing an additional 145 shares during the last quarter. NEXT Financial Group Inc increased its position in shares of Stericycle by 77.9% in the third quarter. NEXT Financial Group Inc now owns 2,322 shares of the business services provider’s stock worth $164,000 after purchasing an additional 1,017 shares during the last quarter. Benjamin F. Edwards & Company Inc. increased its position in shares of Stericycle by 8.5% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 2,540 shares of the business services provider’s stock worth $194,000 after purchasing an additional 200 shares during the last quarter. Cadence Capital Management LLC bought a new position in shares of Stericycle in the third quarter worth approximately $234,000. Finally, Intact Investment Management Inc. bought a new position in shares of Stericycle in the second quarter worth approximately $237,000. Institutional investors own 94.13% of the company’s stock.
In other news, Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction dated Monday, October 30th. The stock was sold at an average price of $70.52, for a total transaction of $1,392,981.56. Following the sale, the director now directly owns 205,576 shares in the company, valued at $14,497,219.52. The sale was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 3.30% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.